Equity Research, Broker Reports, and media content on Shield Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics. We currently have 99 research reports from 8 professional analysts.

Open
166p
Range Today
163/166p
52 Week
35.5/196p
Daily Volume
178.8k
# Shares
117.2m
Daily Liquidity
(0.15%)
Pension Liability
£0m
Enterprise Value
£206.4m
Market Cap
£193.4m
Latest PE (hist)
Div Yield
Date Source Announcement
14Jan20 07:15 EQS Hardman & Co Research: Shield Therapeutics (STX): Taking on China
08Jan20 07:00 RNS China licence agreement for Feraccru/Accrufer
12Dec19 17:30 RNS Eland Oil & Gas
29Nov19 15:31 RNS Holding(s) in Company
25Nov19 07:00 RNS QCA Corporate Governance Code
30Oct19 07:30 EQS Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
22Oct19 07:00 RNS Positive results presented at UEG Week 2019
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics

  • Providers covering

    Shield Therapeutics